GLP-1s May Be Taking Our Eyes Off the Real Obesity Problem

(MedPage Today) -- GLP-1 receptor agonists may be powerful tools for treating obesity and cardiometabolic disease, but relying on medications alone risks overlooking the forces helping drive the obesity epidemic, according to Laura Schmidt, PhD...